Ablation of C/EBP homologous protein increases the acute phase mortality and doesn't attenuate cardiac remodeling in mice with myocardial infarction

Biochemical and Biophysical Research Communications

Volumn 464, Issue 1, 2015, Pages 201-207

  Luo, Guangjin ^a   Li, Qingman ^a   Zhang, Xiajun ^a   Shen, Liang ^a   Xie, Jiahe ^a   Zhang, Jingwen ^a   Kitakaze, Masafumi ^b   Huang, Xiaobo ^a   Liao, Yulin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

C EBP homologous protein; Heart failure; Myocardial infarction

Indexed keywords

C EBP HOMOLOGOUS PROTEIN; PROTEIN; UNCLASSIFIED DRUG; DDIT3 PROTEIN, MOUSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE ANTERIOR WALL THICKNESS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FRACTIONAL SHORTENING; HEART LEFT VENTRICLE POSTERIOR WALL THICKNESS; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE SYSTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART WEIGHT; KNOCKOUT MOUSE; LUNG WEIGHT; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL RATE; SURVIVAL TIME; TUNEL ASSAY; WILD TYPE MOUSE; ANIMAL; DEFICIENCY; DISEASE MODEL; ECHOGRAPHY; GENE DELETION; GENE EXPRESSION; GENETICS; HEART MUSCLE; HEART MUSCLE CELL; HEMODYNAMICS; METABOLISM; PATHOLOGY; SURVIVAL;

MUS;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; GENE DELETION; GENE EXPRESSION; HEMODYNAMICS; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; SURVIVAL ANALYSIS; TRANSCRIPTION FACTOR CHOP; VENTRICULAR REMODELING;

EID: 84937628203     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.06.117     Document Type: Article

References (19)

1. D.J. Hausenloy, and D.M. Yellon Myocardial ischemia-reperfusion injury: a neglected therapeutic target J. Clin. Invest. 123 2013 92 100
2. H.Y. Fu, K. Okada, Y. Liao, O. Tsukamoto, T. Isomura, M. Asai, T. Sawada, K. Okuda, Y. Asano, S. Sanada, H. Asanuma, M. Asakura, S. Takashima, I. Komuro, M. Kitakaze, and T. Minamino Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload Circulation 122 2010 361 369
3. T. Luo, B. Chen, Z. Zhao, N. He, Z. Zeng, B. Wu, Y. Fukushima, M. Dai, Q. Huang, D. Xu, J. Bin, M. Kitakaze, and Y. Liao Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function Basic Res. Cardiol. 108 2013 342 356
4. L. Shen, C. Chen, X. Wei, X. Li, G. Luo, J. Zhang, J. Bin, X. Huang, S. Cao, G. Li, and Y. Liao Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents Clin. Sci. (Lond.) 128 2015 665 678
5. W. Xuan, Y. Liao, B. Chen, Q. Huang, D. Xu, Y. Liu, J. Bin, and M. Kitakaze Detrimental effect of fractalkine on myocardial ischaemia and heart failure Cardiovasc. Res. 92 2011 385 393
6. W. Xuan, B. Wu, C. Chen, B. Chen, W. Zhang, D. Xu, J. Bin, and Y. Liao Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine Crit. Care Med. 40 2012 3026 3033
7. Z. Zeng, L. Shen, X. Li, T. Luo, X. Wei, J. Zhang, S. Cao, X. Huang, Y. Fukushima, J. Bin, M. Kitakaze, D. Xu, and Y. Liao Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis Clin. Sci. (Lond.) 127 2014 435 448
8. A.H. Chaanine, R.E. Gordon, E. Kohlbrenner, L. Benard, D. Jeong, and R.J. Hajjar Potential role of BNIP3 in cardiac remodeling, myocardial stiffness, and endoplasmic reticulum: mitochondrial calcium homeostasis in diastolic and systolic heart failure Circ. Heart Fail. 6 2013 572 583
9. H. Tanjore, W.E. Lawson, and T.S. Blackwell Endoplasmic reticulum stress as a pro-fibrotic stimulus Biochim. Biophys. Acta 1832 2013 940 947
10. Y. Miyazaki, K. Kaikita, M. Endo, E. Horio, M. Miura, K. Tsujita, S. Hokimoto, M. Yamamuro, T. Iwawaki, T. Gotoh, H. Ogawa, and Y. Oike C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation Arterioscler. Thromb. Vasc. Biol. 31 2011 1124 1132
11. K. Okada, T. Minamino, Y. Tsukamoto, Y. Liao, O. Tsukamoto, S. Takashima, A. Hirata, M. Fujita, Y. Nagamachi, T. Nakatani, C. Yutani, K. Ozawa, S. Ogawa, H. Tomoike, M. Hori, and M. Kitakaze Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis Circulation 110 2004 705 712
12. C.B. Chiribau, F. Gaccioli, C.C. Huang, C.L. Yuan, and M. Hatzoglou Molecular symbiosis of CHOP and C/EBP beta isoform LIP contributes to endoplasmic reticulum stress-induced apoptosis Mol. Cell Biol. 30 2010 3722 3731
13. B. Chen, D. Lu, Y. Fu, J. Zhang, X. Huang, S. Cao, D. Xu, J. Bin, M. Kitakaze, Q. Huang, and Y. Liao Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53 Br. J. Pharmacol. 171 2014 3741 3753
14. M. Shimazaki, K. Nakamura, I. Kii, T. Kashima, N. Amizuka, M. Li, M. Saito, K. Fukuda, T. Nishiyama, S. Kitajima, Y. Saga, M. Fukayama, M. Sata, and A. Kudo Periostin is essential for cardiac healing after acute myocardial infarction J. Exp. Med. 205 2008 295 303
15. H. Matsusaka, T. Ide, S. Matsushima, M. Ikeuchi, T. Kubota, K. Sunagawa, S. Kinugawa, and H. Tsutsui Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice Cardiovasc. Res. 70 2006 457 465
16. A. Toth, P. Nickson, A. Mandl, M.L. Bannister, K. Toth, and P. Erhardt Endoplasmic reticulum stress as a novel therapeutic target in heart diseases Cardiovasc. Hematol. Disord. Drug Targets 7 2007 205 218
17. J. Tao, W. Zhu, Y. Li, P. Xin, J. Li, M. Liu, J. Li, A.N. Redington, and M. Wei Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1471 H1486
18. W.F. Cai, T. Pritchard, S. Florea, C.K. Lam, P. Han, X. Zhou, Q. Yuan, S.E. Lehnart, P.D. Allen, and E.G. Kranias Ablation of junctin or triadin is associated with increased cardiac injury following ischaemia/reperfusion Cardiovasc. Res. 94 2012 333 341
19. B. Ibanez, G. Heusch, M. Ovize, and F. Van de Werf Evolving therapies for myocardial ischemia/reperfusion injury J. Am. Coll. Cardiol. 65 2015 1454 1471